- Remove All
- Your shopping cart is currently empty
(S)-AM1241 binds to cannabinoid (CB) receptors and is selective for the CB2 over the CB1 receptor (Kis = 658 and >10,000 nM, respectively, in a membrane assay using human receptors). (S)-1241 acts as an agonist at human, rat, and mouse CB2 receptors but shows greater activity at human CB2 (EC50 = 131 nM) than at rat and mouse CB2 receptors (EC50 = 785 and 2,000 nM, respectively). Similar to the racemate AM1241 , (S)-AM1241 produces antinociception to thermal, but not mechanical, pain in rats. The pain-reducing effect of (S)-AM1241 is blocked by the CB2-specific inhibitor SR 144528 but not by either the CB1-selective inhibitor rimonabant or the opioid receptor blocker naloxone .
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 150 € | 35 days | |
5 mg | 653 € | 35 days | |
10 mg | 1.149 € | 35 days | |
25 mg | 2.517 € | 35 days |
Description | (S)-AM1241 binds to cannabinoid (CB) receptors and is selective for the CB2 over the CB1 receptor (Kis = 658 and >10,000 nM, respectively, in a membrane assay using human receptors). (S)-1241 acts as an agonist at human, rat, and mouse CB2 receptors but shows greater activity at human CB2 (EC50 = 131 nM) than at rat and mouse CB2 receptors (EC50 = 785 and 2,000 nM, respectively). Similar to the racemate AM1241 , (S)-AM1241 produces antinociception to thermal, but not mechanical, pain in rats. The pain-reducing effect of (S)-AM1241 is blocked by the CB2-specific inhibitor SR 144528 but not by either the CB1-selective inhibitor rimonabant or the opioid receptor blocker naloxone . |
Alias | (S)-AM1241 |
Molecular Weight | 503.33 |
Formula | C22H22IN3O3 |
Cas No. | 444912-53-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMF: 25 mg/mL DMF:PBS(pH7.2) (1:2): 0.3 mg/mL Ethanol: 5 mg/mL DMSO: 10 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.